BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 37058032)

  • 1. Role of CCT4/ErbB signaling in nephroblastoma: Implications for a biomarker of Wilms tumor.
    Wang H; Zhang L; Liu B; Su J; Ni X
    Medicine (Baltimore); 2023 Apr; 102(15):e33219. PubMed ID: 37058032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive Analysis of a Long Noncoding RNA-Associated Competing Endogenous RNA Network in Wilms Tumor.
    Zhang F; Zeng L; Cai Q; Xu Z; Liu R; Zhong H; Mukiibi R; Deng L; Tang X; Xin H
    Cancer Control; 2020; 27(2):1073274820936991. PubMed ID: 32597194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-155-5p exerts tumor-suppressing functions in Wilms tumor by targeting IGF2 via the PI3K signaling pathway.
    Luo X; Dong J; He X; Shen L; Long C; Liu F; Liu X; Lin T; He D; Wei G
    Biomed Pharmacother; 2020 May; 125():109880. PubMed ID: 32004974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Weighted gene co‑expression network analysis for identifying hub genes in association with prognosis in Wilms tumor.
    Wang X; Song P; Huang C; Yuan N; Zhao X; Xu C
    Mol Med Rep; 2019 Mar; 19(3):2041-2050. PubMed ID: 30664180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Competitive endogenous RNA (ceRNA) regulation network of lncRNAs, miRNAs, and mRNAs in Wilms tumour.
    Tang F; Lu Z; Wang J; Li Z; Wu W; Duan H; He Z
    BMC Med Genomics; 2019 Dec; 12(1):194. PubMed ID: 31842887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive analysis of long non‑coding RNA using an associated competitive endogenous RNA network in Wilms tumor.
    Wang Z; Cheng H; Qi L; Sui D
    Mol Med Rep; 2020 Jul; 22(1):105-116. PubMed ID: 32377711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-140-5p could suppress tumor proliferation and progression by targeting TGFBRI/SMAD2/3 and IGF-1R/AKT signaling pathways in Wilms' tumor.
    Liu Z; He F; OuYang S; Li Y; Ma F; Chang H; Cao D; Wu J
    BMC Cancer; 2019 Apr; 19(1):405. PubMed ID: 31035970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
    Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
    Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a Potential MiRNA-mRNA Regulatory Network for Osteoporosis by Using Bioinformatics Methods: A Retrospective Study Based on the Gene Expression Omnibus Database.
    Lin S; Wu J; Chen B; Li S; Huang H
    Front Endocrinol (Lausanne); 2022; 13():844218. PubMed ID: 35620387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic values and prospective pathway signaling of MicroRNA-182 in ovarian cancer: a study based on gene expression omnibus (GEO) and bioinformatics analysis.
    Li Y; Li L
    J Ovarian Res; 2019 Nov; 12(1):106. PubMed ID: 31703725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive Analysis of lncRNA-Mediated ceRNA Crosstalk and Identification of Prognostic Biomarkers in Wilms' Tumor.
    Zheng H; Li BH; Liu C; Jia L; Liu FT
    Biomed Res Int; 2020; 2020():4951692. PubMed ID: 32149111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening and identification of key biomarkers of papillary renal cell carcinoma by bioinformatic analysis.
    Xu Y; Kong D; Li Z; Qian L; Li J; Zou C
    PLoS One; 2021; 16(8):e0254868. PubMed ID: 34358255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-363-3p promote the development of acute myeloid leukemia with RUNX1 mutation by targeting SPRYD4 and FNDC3B.
    Chen Y; Chen S; Lu J; Yuan D; He L; Qin P; Tan H; Xu L
    Medicine (Baltimore); 2021 May; 100(18):e25807. PubMed ID: 33950983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Key Biomarkers and Potential Molecular Mechanisms in Oral Squamous Cell Carcinoma by Bioinformatics Analysis.
    Yang B; Dong K; Guo P; Guo P; Jie G; Zhang G; Li T
    J Comput Biol; 2020 Jan; 27(1):40-54. PubMed ID: 31424263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated miRNA-mRNA network revealing the key molecular characteristics of ossification of the posterior longitudinal ligament.
    Xu G; Liu C; Liang T; Qin Z; Yu CJ; Zhang Z; Jiang J; Chen J; Zhan X
    Medicine (Baltimore); 2020 May; 99(21):e20268. PubMed ID: 32481304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of crucial miRNAs and genes in esophageal squamous cell carcinoma by miRNA-mRNA integrated analysis.
    Zhong X; Huang G; Ma Q; Liao H; Liu C; Pu W; Xu L; Cai Y; Guo X
    Medicine (Baltimore); 2019 Jul; 98(27):e16269. PubMed ID: 31277149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Serum Exosome-Derived circRNA-miRNA-TF-mRNA Regulatory Network in Postmenopausal Osteoporosis Using Bioinformatics Analysis and Validation in Peripheral Blood-Derived Mononuclear Cells.
    Dong Q; Han Z; Tian L
    Front Endocrinol (Lausanne); 2022; 13():899503. PubMed ID: 35757392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of key genes and microRNAs involved in kidney Wilms tumor by integrated bioinformatics analysis.
    Zhang L; Gao X; Zhou X; Qin Z; Wang Y; Li R; Tang M; Wang W; Zhang W
    Exp Ther Med; 2019 Oct; 18(4):2554-2564. PubMed ID: 31555364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Key Genes Associated with Pyroptosis in Gout and Construction of a miRNA-mRNA Regulatory Network.
    Bai B; Liu Y; Abudukerimu A; Tian T; Liang M; Li R; Sun Y
    Cells; 2022 Oct; 11(20):. PubMed ID: 36291136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma.
    Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K
    Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.